Anesthesiology Doctors in Du Bois, PA Accepting Medicare

8 Anesthesiology doctors found. Showing 1 - 8

Dr. Paul J Valigorsky Ii, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Ave, Du Bois, PA 15801 Phone: 814-375-3034

Dr. Spring Marie Mccann, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Ave, Du Bois, PA 15801 Phone: 814-371-2200    Fax: 814-375-3384

Dr. Thomas F Eckert, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Ave, Du Bois, PA 15801 Phone: 814-371-2200    Fax: 814-375-3384

Dr. Eduardo C. Lomibao, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 100 Hospital Ave, Du Bois, PA 15801 Phone: 814-371-2200    Fax: 814-375-3384

Thomas B Gentilcore, M.D Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Ave, Du Bois, PA 15801 Phone: 814-371-2200    Fax: 814-375-3384

Dr. Karl Wong, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 100 Hospital Ave, Du Bois, PA 15801 Phone: 814-375-3286    Fax: 814-375-3384

Constance M Linn, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Ave, Du Bois, PA 15801 Phone: 814-371-2200

Kevin Patrick Morrissey, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Ave, Du Bois, PA 15801 Phone: 814-375-3286    Fax: 814-375-3384

News Archive

Surveying the landscape from bench to bedside

The Obama administration is planning a decade-long scientific effort to examine the workings of the human brain and build a comprehensive map of its activity, seeking to do for the brain what the Human Genome Project did for genetics.

Winston submits NDA for CIVANEX to U.S. FDA

Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc., a pharmaceutical company focused on developing and commercializing novel pain management therapies, announced that it has submitted a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) for approval to market its civamide (zucapsaicin) 0.075% cream, CIVANEX®, for the treatment of signs and symptoms of osteoarthritis of the knee.

LRF's 2009 Mantle Cell Lymphoma Consortium report published

Highlights from the Lymphoma Research Foundation (LRF) 2009 Mantle Cell Lymphoma Consortium (MCLC) Scientific Workshop will be published in the March 2010 issue of Leukemia & Lymphoma. Traditionally accessible to subscribers for period of one year, Leukemia and Lymphoma has agreed to make this report available to the public for one month - Mantle Cell Lymphoma: Report of the 2009 MCL Consortium Workshop.

Type 2 diabetes diagnosis may increase immediate risk of developing cancer

A new study indicates that individuals with diabetes may have an elevated risk of developing cancer before and immediately after a diabetes diagnosis. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings point to the need for a better understanding of the link between diabetes and cancer.

Read more Medical News

› Verified 6 days ago